Company Filing History:
2 out of 2 
1 out of 1 Years Active: 2015-2016
Title: Innovations of Mingxin Wang
Introduction
Mingxin Wang is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target neurotransmitter systems. With a total of 2 patents, his work reflects a commitment to advancing medical science.
Latest Patents
Mingxin Wang's latest patents include a glycine reuptake inhibitor and a norepinephrine and selective serotonin receptor blocker. The glycine reuptake inhibitor is a compound designed to enhance glycine levels in the brain, which may have therapeutic implications for various neurological conditions. The norepinephrine and selective serotonin receptor blocker is another innovative compound that aims to regulate mood and anxiety by targeting specific neurotransmitter receptors.
Career Highlights
Throughout his career, Mingxin Wang has worked with several prominent companies, including Beijing Medisan Technology Co., Ltd and Harbin Medisan Pharmaceutical Co., Ltd. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the pharmaceutical industry.
Collaborations
Mingxin Wang has collaborated with notable colleagues such as Jinai Liu and Fan Yang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Mingxin Wang's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of new therapeutic compounds.